Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: A Study to Detect the Radioactivity of 14C-SEP-380135 in Urine and Feces in Healthy Male Adults [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial to detect the radioactivity of the radiolabeled compound SEP-380135 (14C) in urine and feces in healthy male adults, sponsored by Otsuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEP-380135 (SEP-380135)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia | Phase 1 | Status: NOT_YET_RECRUITING